The spatiotemporal expression of genes is controlled by enhancer sequences that bind transcription factors. Identifying the target genes of enhancers remains difficult because enhancers regulate gene expression over long genomic distances. To address this, we used an evolutionary approach to build two genome-wide maps of enhancer-gene associations in 5 the human and zebrafish genomes. Enhancers were identified using sequence conservation, and linked to their predicted target genes using PEGASUS, a bioinformatics method that relies on evolutionary conservation of synteny. The analysis of these maps revealed that the number of enhancers linked to a gene correlate with its expression breadth. Comparison of both maps identified hundreds of vertebrate ancestral regulatory relationships from which 10 we could determine that enhancer-gene distances scale with genome size despite strong positional conservation. The two maps represent a resource for further studies, including the prioritisation of sequence variants in whole genome sequence of patients affected by genetic diseases.
Introduction 15
Enhancers are short DNA sequences that bind transcription factors and contact promoters in cis to activate or repress the transcription of genes into RNA 1 . This control -or regulation -of gene expression by enhancers ensures the fine tuning of mRNA abundance in cells. Disruption of enhancer function has been shown to lead to abnormal gene expression and thus to disease [2] [3] [4] . In addition, the majority of variants identified in Genome Wide 20
Association Studies (GWAS) are found outside coding sequences 5 . Together with the observation that many patients remain undiagnosed after genome sequencing because no plausible coding variant can be incriminated 6 , these considerations underscore the importance of identifying enhancers and their target genes to better understand genome function. 25
Numerous methods have been developed to identify enhancers across entire genomes. Early methods were based on the analysis of the evolutionary conservation of non-coding sequences [7] [8] [9] . More recently, the rise of next generation sequencing technologies has enabled large-scale epigenomics projects to map regulatory regions in a genome, e.g. enhancerassociated histone modifications 10, 11 , open chromatin regions 12 or binding of enhancer-30 associated proteins on the genome 13, 14 . Of note, these approaches predict enhancers through indirect evidence for regulatory function, and do not associate predicted enhancers to their target genes. Although choosing the nearest gene is often used as default 15 , the fraction of enhancers regulating their nearest flanking gene is not known. In fact, it is known that enhancers can regulate genes over long distances, sometimes several hundreds of 35 kilobases (kbp) away, sometimes bypassing other genes 16, 17 . The classical case of the Shh gene in mouse demonstrates this quite directly as mutations affecting its expression in the intron of the lmbr1 gene located approximately 1 Mb away 16 .
Linking long distance regulatory regions to the genes they regulate is important to study and understand the function of enhancers. Three main categories of experimental methods have 40
been developed to assign enhancers to target genes in a genome-wide manner. The first uses chromosomal conformation capture techniques to identify physical interaction between two loci in the genome [18] [19] [20] [21] . The second measures the correlation of transcription activity between non-coding sequences and nearby genes 22 , assuming the two are signatures of a coordinated regulatory function. Finally, non-coding single nucleotide variants (SNVs) can be 45 associated to significant differences in nearby gene expression, thus qualifying as expression QTL (eQTL) that presumably reside within or close to enhancers 23 . These experimental methods are -by definition -specific to the cell-type or tissue where the experiment is carried out and have been applied mostly in human and mouse genomes, while entire group of vertebrate species (e.g. fish) have no available predictions. The use of methods based on 50 evolutionary principles could solve these difficulties, because they do not depend on the specific biological contexts required by experimental assays and are more easily applicable to multiple species.
We previously developed such a method called PEGASUS (Predicting Enhancer Gene ASsociations Using Synteny), a computational method to predict enhancers and their target 55 genes using signals of evolutionary conserved linkage (or synteny) 24 . The rationale underlying PEGASUS postulates that an evolutionary genomic rearrangement would dissociate a cisacting enhancer from its target gene, and would therefore be deleterious. Negative selection would hence result in the preservation of local synteny between enhancers and their target gene. PEGASUS works in a cell-type or tissue agnostic manner and relies only on the analysis 60 of evolutionary signals. This is of particular interest for regulatory functions important during human development, where experimental assays are limited. This method was originally tested on the human X chromosome followed by experimental validations of more than 1,000 predicted interactions using transgenic assays 24 .
Here, we applied PEGASUS on the entire human and zebrafish genomes to generate two 65 independent genome-wide maps of predicted enhancer-gene interactions. We exploit these resources to uncover evidence for a direct link in the human genome between the number of predicted enhancers associated with a gene and the number of tissues it is expressed in. By comparing these maps, we outline a set of genes with conserved cis-regulation in vertebrates enriched in brain and development functions. We find that the average distance 70
separating predicted enhancer and their target genes scales with genome size, suggestive of weak selective pressure preserving this distance. Finally, our collections of predicted enhancers-gene associations are a valuable resource for the community, represent testable hypotheses that should facilitate genomic studies (e.g. linking transcription factor ChIP-seq peaks to predicted targets) and accelerate the interpretation non-coding variants in whole 75 genome sequences from patient.
Results

Enhancers -target genes maps in the human and zebrafish genomes
We predicted enhancers in the human and zebrafish genomes as Conserved Non-coding Elements (CNEs) and applied the PEGASUS method 24 to predict their most likely target 80 genes. PEGASUS assigns to a CNE the gene(s) within a pre-defined radius (set arbitrarily to 1Mb in both human and zebrafish) with the most conserved synteny (linkage between a gene and its CNE), which we quantify using an evolutionary linkage score ( Figure 1a ). For the human genome, we first analysed the UCSC 100-way multiple genome alignment restricted to 35 non-teleost fish vertebrates with good genome reconstruction quality (methods) to 85 identify 1,376,482 human CNEs. We applied PEGASUS on these elements and assigned over 95% of these CNEs (1,311,643) to 18,339 human genes (out of 20,342 protein coding genes in the human genome, Figure 1d ). Human CNEs cover 2.5% of the genome. For zebrafish, we generated a multiple alignment of 7 teleost fish genomes (methods), leading to the identification of 111,281 CNEs, 50% of which (55,515) could be linked to 17,363 genes (out 90 of 26,427 protein coding genes in the zebrafish genome). These CNEs cover 0.5% of the zebrafish genome ( Supplementary Figure 2 ). The lower sensitivity in identifying zebrafish CNEs can be explained by phylogenetic sampling differences between the two species (see Discussion and Supplementary materials). The majority of CNEs are close to their target genes: the median CNE-TSS distance is 353 kbp in human and 289 kbp in zebrafish ( Figure  95 1b).
The zebrafish enhancer-gene map presented here is the first genome wide resource of its kind. Of note, the human and zebrafish analyses were performed using distinct sets of genomes, enabling rigorous comparisons between phylogenetically independent datasets.
PEGASUS can predict enhancer-gene interactions that skip over unrelated genes. We found 100 that a large fraction of these "jumping" (CNEs skipping over intervening genes to connect to their linked genes) interactions in the human and zebrafish genomes, 27% and 49% respectively ( Figure 1c ). Moreover, 34% of these "jumping" CNEs in human and 37% in zebrafish are located in an intron of a gene that is not their target gene.
PEGASUS is an in-silico method entirely based on evolutionary signals to identify the target 105 genes of CNEs. We evaluated how our predictions coincide with in-vivo inferences of regulatory regions (histone modifications 10, 25 or experimental enhancer predictions 22, 26, 27 ). Invivo inferred regulatory regions overlap well our PEGASUS CNEs (up to 95% overlap, up to 4-fold increase over random expectations, Table 1 ). Finally, we could see a positive link between the PEGASUS linkage score and the overlap between PEGASUS CNEs and in-vivo / 110
in-vitro predicted enhancers & regions with regulatory activity (see Supplementary Material for more details).
We further analysed how PEGASUS in-silico target gene assignments coincide with in-vivo inferences (conformation capture 19, 21 or expression QTLs 23 ). Of note, these in-vivo inferences are currently available only for the human genome. We filtered one-to-one overlapping 115 regulatory regions (one and only one PEGASUS CNE overlapping one and only one other regulatory region) predicted to target only one gene and found that between 21% and 27% of target gene assignments were identical between PEGASUS and Capture Hi-C methods and up to 42% between PEGASUS and eQTLs (see Supplementary Material for more details). Interestingly, these numbers were in the same range as what is observed when 120 comparing eQTLs inferences and Capture Hi-C inferences: from 10% to 48% depending on the cell type (10% for ESCs,16% for NECs, 38% for CD34 and 48% for GM12878 cells; see Discussion).
Finally, we show that enhancer-gene associations predicted by PEGASUS are consistent with the 3D organisation of the human genome, because they are located inside topologically 125 associating domains (TADs 28 ) more often than expected by chance (proportion tests pvalues < 10 -15 , Supplementary Figure 7 ; see Supplementary Material for more details).
Genes with more enhancers are expressed in more tissues Genes cover a broad range of tissue specificities, from 'housekeeping genes' required for generic cellular functions and expressed in most tissues to tightly regulated developmental 130 genes sometimes expressed in just a few cells in a short window of time. It naturally follows that the number of enhancers regulating a gene might directly influence the breadth of a its expression pattern, although this has never been demonstrated. We used enhancer-gene interactions predicted by PEGASUS in the human genome to investigate this question, using expression data from the Bgee database 29 . We observe a positive link between the number 135 of adult tissues where a gene is expressed and the number of CNEs targeting this gene (Spearman's ρ = 0.23, p-value < 10 -15 , Figure 2a ).
Genes with promoters falling into CpG islands (regions of elevated CpG content; methods) are usually broadly expressed while other genes are more tissue-specific [30] [31] [32] . We therefore sought to further disentangle the link between CNE number and expression breadth by 140 taking the CpG dinucleotides content of gene promoters into account. We split our target genes between those with a transcription start site (TSS) overlapping a CpG island (referred to as CpG genes) and other genes (referred to as non-CpG genes). The correlation between CNE number and number of tissues is positive in both sets of genes. This link appears to be stronger for non-CpG genes than for CpG genes (Spearman's ρ = 0.30 & 0.15, respectively, 145
both p-values < 10 -15 , Figure 2 ) but this is explained by the narrower range of tissue where non-CpG island genes are expressed, leading to different ranges of tissue number for both sets of genes ( Supplementary Figures 8 & 9 ).
Conversely to what is observed for genes, CNEs close to their targets tend to be active in more tissues. We computed the correlation between the CNE-TSS distance and the number 150 of tissue a CNE is predicted to be active in, using histone modifications from the Encode project (H3K4me1 and H3K27ac 10 ). We found a negative correlation between the number of tissues and the CNE-TSS distance (Spearman's ρ = -0.16 & -0.14 respectively, both pvalues < 10 -15 , Figure 2b ).
Function of regulatory interactions conserved in vertebrates 155
We defined orthologous CNE-gene associations between the human and zebrafish genomes to study features associated with this conservation of regulatory linkage. Such conserved linkage between enhancers and target genes is consistent with a common origin in the ancestor of Euteleostomi (bony vertebrates), the last common ancestor of human and zebrafish. We identified ~2,000 CNEs conserved between human and zebrafish (1,986 in 160 human, 1,949 in zebrafish) associated by PEGASUS to ~600 human-zebrafish orthologous genes (567 human genes, 607 zebrafish genes, see methods). Functional enrichment analyses show that these ancestral regulatory associations are highly enriched in neuronal functions and development (Tables 2 & 3 ). 30% of these predicted associations are annotated as "jumping" over one or more genes in both species. This includes DMRTA2, a transcription 165 factor involved in female germ cell development 33 and in brain development 34 , or TSHZ1, a member of the teashirt gene family involved in olfactory bulb development 35 . The strong enrichment in core developmental functions observed with orthologous PEGASUS predictions (Table 3) is consistent with earlier observations, as enhancers identified through sequence conservation are often found to be active during development, especially in the 170 nervous system 7, 8, 36, 37 .
We validated a predicted ancestral association using a CRISPR-Cas9 mediated knock-out approach. We focused on one CNE of the zebrafish genome, predicted to be associated with a single gene named irx1b. This gene plays multiple roles during pattern formation of vertebrate embryos 38, 39 , and we expect its expression pattern to be tightly regulated by a 175
complex array of enhancers. The CNE has evidence for a functional activity during development: it overlaps H3K27ac and H3K4me1 marks as well as ATAC-seq peaks ( Figure  3a ) and is conserved in all vertebrates. The human orthologous CNE is associated by PEGASUS to IRX1 and IRX2 and also shows evidence for a functional role in this species (H3K4me1 & H4k27ac 10 ) as well as sequence conservation. The deletion of the CNE greatly 180 decreases the expression of the endogenous gene in several structures of the zebrafish embryo (Figure 3b ,c) establishing it as a bona fide developmental enhancer. Interestingly, the CNE targeted by the deletion is closer to another gene, irx4b, without being associated to it by PEGASUS (Figure 3d ), yet the expression of this gene is unaffected by the absence of the CNE (Figure 3e ). This further illustrates that choosing the nearest gene as a target of a 185
putative enhancer can lead to false predictions and that PEGASUS can distinguish the correct gene target among closely spaced genes.
Enhancers-gene distances scale with genome size
The "action range" of enhancers is known to encompass a wide span, from within the target gene itself to more than 1 Mb away 16, 17 . Importantly, it has been shown that enhancers can 190 change localization within a TAD without affecting downstream gene regulation 40 . Together with results showing high rates of enhancer turnover between species 41, 42 , these observations show on specific examples that little selective constraints exist on maintaining enhancers in a specific position relative to their target genes. We test this hypothesis genome wide using the ~2,000 predicted gene-enhancer associations conserved between 195
human and zebrafish (two genomes with different sizes, 3.1 Gb and 1.5 Gb respectively). We estimated the relative neutral evolution of genomic distances using the sizes of orthologous introns, which are thought to be under negligible size constraint. Results show that distances between orthologous CNEs and their orthologous target genes scale with intron size (median CNE-TSS distance ratio = 2.23, median intron length ratio = 2.39, Figure 4a ). There 200 is therefore no evidence for a constraint on CNE-gene distances, which validates our hypothesis. Perhaps surprisingly, despite this absence of selective constraint on interaction distances, we note that the positions of CNEs relative to their target gene TSS (i.e. whether a CNE lies on the 5' or the 3' side of the TSS) is highly conserved. We found that more than 91% of orthologous CNEs are located on the same side of their TSS in the human and 205 zebrafish species (30.6% on the 5' side and 60.9% on the 3' side, Figure 4b ).
Discussion
We applied the PEGASUS method to identify ~1,300,000 human and ~55,000 zebrafish predicted enhancers (conserved non-coding elements) targeting the majority of the genes in their respective genomes. After finding evidence for a regulatory role of these interactions, 210
we show that regulatory interactions ancestral to vertebrates concentrate on core functions necessary to build an organism, that the number of predicted enhancers associated to a gene positively correlates with its breadth of expression and that the distance between predicted enhancers and their target gene evolves neutrally. Our catalogue of enhancer-gene associations contributes to the study of gene regulation by enhancers in vertebrates, can be 215 easily used in a variety of studies and can improve our understanding of gene functions in particular biological contexts.
The first PEGASUS published set of associations was restricted to the human X chromosome 24 . Here, we significantly improve our knowledge of enhancers in vertebrates by applying PEGASUS to the entire human genome, and in the zebrafish genome where no set 220 of enhancer-gene association exists to-date. Moreover, this catalogue can be used to guide and improve the interpretation of epigenomics data such as histone modifications or open chromatin regions or of sequence variants found to be associated to a particular disease in large-scale sequencing projects.
Effects of phylogenetic sampling 225
We identified a contrasted number of CNEs between human and zebrafish (~1,300,000 and ~55,000, respectively). This discrepancy could be explained by differences in phylogenetic sampling, i.e. the number of species and their phylogenetic relationships used for predicting enhancers and linking them to their target gene. Zebrafish was compared to only 6 other genomes, with zebrafish being an outgroup to all but the spotted gar ( Supplementary Figure  230  1B ). In contrast, human was compared to 35 other genomes (Supplementary Figure 1A) . We tested the influence of this phylogenetic sampling by comparing the human genome to 6 other genomes that mirror the phylogenetic relationships in the zebrafish study (human being an outgroup to all but one species and equivalent phylogenetic distances as in the fish phylogeny, Supplementary Materials). In this reduced set, we could identify approximately 235 253,620 CNEs, of which 193,085 (~82%) target 13,398 genes, a sharp reduction compared to the set identified with a full phylogenetic sampling. The relatively small number of CNEs identified in the zebrafish genome can therefore be explained by the lower number of fish species that can be used for comparative analyses. The addition of more fish species will improve predicted enhancers identifications in the near future. 240
The challenges of predicting long-distance regulatory interactions PEGASUS genome-wide in-silico CNE-target gene predictions allow us to directly compare PEGASUS with genome-wide in-vitro approaches: we found that PEGASUS predictions and in-vitro predictions agree up to 42% of the time. Most in-vitro methods currently employed to predict long-range regulatory interactions in the human genome rely on specific cell 245 lines [19] [20] [21] [22] [23] . These methods usually differ in their approach and the cell types or tissues they study, which might limit expectations to observe overlap in their predictions, especially given that many enhancers are tissue-specific 11, 20, 43 . It is therefore interesting to observe that the level of agreement between eQTLs-based predictions 23 and Capture Hi-C predictions 19, 21 is equivalent to that observed between these and PEGASUS. In contrast, PEGASUS is agnostic 250 to cell-type or tissue context. The sole rationale underlying the predictions is that the interactions are functional, therefore under sufficient evolutionary conservation to be identified by comparisons with other genomes. Moreover, PEGASUS is able to predict enhancer-gene regulatory interactions that "jump" over one or more genes, which reflects the biology of gene expression regulation more accurately than "nearest gene" approaches. 255
Such "nearest gene" methods are often used to define target genes when studying predicted regulatory regions from epigenomics data (e.g. GREAT 15 ). This is a crucial point as experimental methods find a large fraction of these interactions to be "jumping": between 12% in CD34 cells to 33% in ESCs in Capture Hi-C data, 21% for eQTLs: these interactions will be completely missed by "nearest gene" approaches. 260 PEGASUS identifies more than 40% of enhancer-gene interactions observed in experimental assays carried out in human cell lines (see Supplementary Figure 4 ). A much higher overlap may not be expected because the reliance of PEGASUS on evolutionary constraints tend to enrich for interactions active during development 7, 13 , and these are typically harder to identify in differentiated cell lines. In addition, given the rapid evolutionary turnover of 265 enhancer regions during evolution 41, 42, 44 , it is likely that a fraction of cell-type specific enhancers have had little time to leave detectable footprints of selection in a genome. For the same reasons, PEGASUS will fail to capture species-specific or recently evolved regulatory interactions. We observed a general trend for predictions, whether experimental or evolutionary based, to overlap consistently less with increasing distance between the 270 predicted enhancer and the TSS of the target gene ( Supplementary Figures 4 & 6 ) Our data suggests that this could be explained by long distance enhancers being more tissue-specific than short distance enhancers ( Figure 2b) : short distance enhancers have a regulatory action in more tissues and more likely to have the same predicted target gene when comparing tissues or cell types. 275
No evidence for natural selection acting on enhancer-gene distances
Enhancer regulation is mediated through the 3D organisation of the genome. Enhancer-gene interactions occur mostly within TADs 45 , large units of chromosomal interactions largely conserved between cell types and species 28, 46 , via DNA looping 47 . Consistent with observations that the distance between an enhancer and its target within a TAD has no 280 effect on its regulatory potential 40 , we show that CNE-TSS interaction evolution between human and zebrafish follows the same pattern as intron size evolution. A recent analysis of genomic regulatory blocks (or GRBs) in metazoans based on the analysis of clusters of conserved non-coding elements showed that these blocks correlate well with known TADs and their sizes seem to correlate well with genome size 48 , providing further evidence that 285
interaction distances between enhancers and target genes are under the same forces that affect genome size in metazoans. Interestingly, our results show that this lack of selective constraint on interaction distances comes with a strong conservation of relative CNE-TSS orientation.
This study provides a unique view of the conservation and evolution of enhancers in 290 vertebrate genomes. Our results based on evolutionary and comparative genomics are complementary to and consistent with genome-wide experimental observations. They support a model where the number of enhancers controlling a gene drives its expression breadth. They also highlight the biological functions with conserved regulation since the vertebrate ancestor. Moreover, the PEGASUS method provides a robust tissue and life stage 295 agnostic target gene prediction method that opens research possibilities in the study of gene regulation in a wide number of species.
Materials & Methods
Defining conserved non-coding elements and their most likely target genes
We used a previously published method to predict enhancers and their most likely target 300 genes 24 . This method first predicts enhancers as conserved non-coding elements (or CNEs for short) in multiple genome alignments, and second links a CNE to its most likely target gene(s) as the gene in its vicinity with the most conserved synteny, through the computation of a linkage score measuring this conservation.
We identified CNEs in the human and zebrafish genomes in multiple alignments as follows. 305
We first identified seeds of 10bp with at least 9 alignment columns conserved between all species considered. These seeds were then extended on both sides, allowing up to three non-conserved alignments columns. We allowed up to 40% of mismatches in a column to consider it as conserved for zebrafish and up to 88% for human. For the human genome (GRCH37-hg19 version), we used the UCSC 100-way multiple alignments restricted to 35 310
Sarcopterygii species with a scaffold N50 of at least 1 Mb (a full list is available in Supplementary Table 1 ). Alignment blocks had to contain at least 6 species (including human) with one non-primate species to be considered. For the zebrafish genome (danRer7/Zv9 version), we generated multiple alignments that include 6 other Neopterygii species (a full list is available in Supplementary Table 2 ). Multiple alignments were built first by pairwise 315
alignments between zebrafish and other species using LastZ 49 , then by using these to build multiple alignments with Multiz 50 . Alignment parameters can be found in Supplementary Materials. Alignments blocks had to contain at least 3 species (including zebrafish) to be considered.
We used PEGASUS 24 to identify target genes in both genomes. This method first identifies all 320 protein coding genes (ENSEMBL 75) in a 1 Mb radius around CNEs. It then computes a linkage score for each gene, reflecting the evolutionary conservation of synteny between a CNE and a particular gene. For each gene around a CNE present in N species, the linkage score is computed as follows (equation 1 from 24 ):
Where C e is a corrective factor to take assembly errors from low-coverage sequences into account, R e the rearrangements rate between human or zebrafish and the species e, S e,0 , S e,1 , S e,2 and S e,3 the respective status of the orthologous gene considered in species e (absent or mis-annotated, present and within the correct radius, present and outside the radius, present and on a different chromosome, respectively). The radius in each species is 1Mb 330 corrected by the genome size of species e normalised by the human or zebrafish genome size. R e is computed as (equation 2 in 24 ):
Where G is the number of gene pairs in the human or zebrafish genome and P e the number of these pairs that are direct neighbours in species e. The linkage score is then normalised in 335 a [0,1] interval using a sigmoid transformation (equations 3, 4 & 5 in 24 ). For a given CNE, the gene with the highest linkage score is defined as its most likely target gene. If more than one gene have the highest linkage score, they all are defined as most likely targets. Adjacent CNEs targeting identical gene, present in the same species, having identical linkage scores and distant by less than 100bp were merged together. CNEs located at 100bp or less from 340 an exon were discarded.
Overlap with functional marks & enhancer predictions
We investigated the link between our PEGASUS predictions and functional marks and previous in vivo enhancer annotations. We first computed the overlap with ChIP-seq peaks of histone modifications (namely H3K27ac, H3K4me1, H3K4me3 and H3K27me3) in 345 embryonic stem cells in human 10 and across various developmental stages in zebrafish 25 . We also computed the overlap between our CNEs and ATAC-seq peaks in zebrafish 51 and DNase 1 ChIP-seq peaks in human 10 . We finally computed the overlap between our CNEs and other enhancer predictions: we used enhancer predictions from the FANTOM project 22 or from the Vista database 26 for human, and from differentially methylated regions 27 in 350
zebrafish. For all computations, all overlap of at least 1bp were considered. We compared observed overlaps with random overlaps by shuffling CNEs coordinates along the human and zebrafish genomes. Fold enrichments were computed as the ratio between the number of invivo or in-vitro-predicted regulatory regions overlapping PEGASUS CNEs and the number of regions overlapping shuffled PEGASUS CNEs. 355
Gene expression data
Gene expression values and calls for the human genome were downloaded from the Bgee database 29 . For each gene, we computed the number of adult tissues for human or developmental stage for zebrafish in which a gene is called as expressed. We filtered out terms (stages or tissues) that had daughter terms for the same gene. 360
Comparing target gene predictions with in vivo predictions
We compared PEGASUS enhancer-gene predictions in human with other predictions based on eQTLs in various tissues 23 or on Capture Hi-C data in CD34 and GM12878 cells 19 and in embryonic stem cell (ESCs) and ESC-derived neurodectodermal cells (NECs) 21 . The latter contains interactions present in one cell type or in both simultaneously (labelled "Both"). We 365 considered only CNEs with a one to one overlap (one and only one PEGASUS CNE overlapping one and only one other predicted enhancer), and both targeting only one gene. In this set of PEGASUS enhancers and other enhancers, we computed for each cell type the percentage of PEGASUS predictions and other prediction that agreed with each other.
Defining orthologous enhancers & target genes between human & zebrafish 370
We downloaded human-zebrafish and zebrafish-human pairwise chain alignments from UCSC. We defined orthologous CNEs as human and zebrafish CNEs that overlapped by at least 10bp on either pairwise alignment. We next downloaded human-zebrafish orthologous genes from the Ensembl database (version 75) 52 to identify orthologous enhancers targeting orthologous genes. 375
Because of the evolutionary distance between human and zebrafish, some orthologous regions are difficult to align and are thus impossible to detect. To circumvent this problem, we used the spotted gar genome 53 to identify additional orthologous CNEs. We downloaded human-spotted gar pairwise chain alignments and used our custom-made zebrafish-spotted gar pairwise chain alignments to respectively map human and zebrafish CNEs onto the 380 spotted gar genome. We considered human and zebrafish CNEs as orthologous if they overlapped by at least 10bp on the spotted gar genome. No information other than orthology of CNEs on the spotted gar genome was used. We identified orthologous targets by looking at the orthologous genes set used above. Orthologous CNEs identified both directly and via the spotted gar were combined. 385
Gene enrichment analysis
We performed anatomical terms enrichment analyses using the TopAnat webtool of the Bgee database 29 and the PantherDB webtool 54 . The test set was defined as human-zebrafish orthologous genes with conserved CNEs defined above. The control set was defined in both species as all genes targeted by at least one CNE. 390
Distance to transcription start sites
We downloaded transcription start sites (or TSS) locations from the Ensembl database (version 75) 52 . For each gene, we considered only the transcript giving the longest protein.
We computed for each enhancer-gene the distance to the TSS as the shortest distance from 395 enhancer boundary to the target's TSS.
CNE activity breadth prediction
We computed each CNE's activity breadth by computing in how many tissues a particular CNE overlaps a histone modification ChIP-seq peak. We focused on H3K27ac and H3K4me1, using ChIP-seq data from the ENCODE project 10 . 400
Topologically associating domains
We downloaded topologically associating domains (or TADs) coordinates for two cell types, human embryonic stem cells (hESCs) and IMR90 fibroblasts 28 . We converted these coordinates from hg18 to hg19 using the liftOver utility available at the UCSC genome browser 55 . For CNEs targeting only one gene, we computed for each cell type whether both 405
an enhancer and its target gene were located within the same TAD. We also computed random overlap between TADs and regulatory interactions by shuffling the localisation of the TAD domains along the human genome and computing the overlap between PEGASUS interactions and these shuffled TADs.
In vivo validation
410 Vector and cloning:
The predicted Irx1b CNE (chr19_2681: chr19:28704114-28704349, danRer7 version of the zebrafish genome) was amplified from zebrafish genomic DNA using the following primers: CNE-Irx1b-Forward: 5'-TGAATGCTCATCCGGAACATCCACTGCTGCTCCCAAAG-3'; CNE-Irx1b-Reverse: 5'-GACCTGCAGACTGGCAGTTCCTCGCCAGAGCTCAG-3' and 415
cloned into pZED plasmid 56 upstream of the minimal GATA2 promoter/GFP reporter.
Zebrafish egg injections for transgenesis: The Tol2 transposon/transposase method of transgenesis 57 was used with minor modifications. Two nanoliters containing 20 ng/µl of transposase mRNA and 30 ng/µl of phenol/chloroform purified pZED construct were injected in one-cell stage embryos. 420
In situ hybridization: In situ hybridization were performed as described 58 , using an Irx1b probe corresponding to exon 2.
Zebrafish egg injections for mutagenesis: Three RNAs targeting three ultra-conserved sequences in the CNE were designed as 425
follows: CNE-Irx1b-guide1: TCCGTCACGCTGAGATAATC; CNE-Irx1b-guide2: TCAAACACTTTGGGGAACAA; CNE-Irx1b-guide3: TGACCTCTCACCTCGGGCTA. Similarly, three RNAs targeting three ultra-conserved sequences in a random genomic region were designed as follows: Control-guide1: TTGCTTCTGCGCTGAAATAA; Control-guide2: ATGGACTAAAAATTTCACTT; Control-guide3: GAATGTTGATTGTAATTACA. 430
They were purchased from Integrated DNA Technologies as "crRNA", hybridized with their "tracrRNA", forming the guide RNA (gRNA) and incubated with a Cas9 protein (gift from J-P. Concordet). Three nanoliters containing a mix of the 3 resulting ribonucleoproteins (Cas9/gRNA) targeting either the control or the predicted Irx1b enhancer were injected at 15µM each. 435 34 embryos showed a signal for decreased gene activity over 37 embryos tested.
Data availability
PEGASUS predictions for the human genome (hg19), the zebrafish genome (danRer7) as well as interactions predicted to be conserved between both genomes are available here: ftp://ftp.biologie.ens.fr/pub/dyogen/PEGASUS/ 440 (a) Link between the number of CNEs targeting a gene and the number of tissues it is expressed in, for all genes or separating between CpG TSS genes and others. Genes were divided in twenty classes of identical size based on their number of CNEs. Classes were made independently for all genes, for CpG genes & for non-CpG genes. Points and vertical 625 lines represent mean number of tissues or life stages with 95% confidence interval in each class. Correlation coefficients were computed on unbinned data. Genes were classified as CpG TSS or non-CpG TSS based on the overlap of their TSS with CpG islands. (b) Link between CNE-TSS distance and predicted CNE activity breadth. CNE activity breadth was computed as the number of tissues for which a CNE overlaps a histone modification ChIP-630 seq peak. ChIP-seq data comes from the ENCODE project 10 . CNEs were divided in independent classes according to their CNE-TSS distances (one class covers 50kbp). Points and vertical lines represent mean number of tissues with 95% confidence interval in each class. Correlation coefficients were computed on unbinned data. 635 Figure 4 : Distances between CNEs and target genes scale with genome size.
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